The COVID-19 outbreak has taken a staggering toll globally. There will be further layers of deferred or indirect impact that might postpone the treatments or cancel it, long-term and unknown health impacts for those patients who has recovered from the COVId-19 pandemic, the health effect on the physical and behavioral aspects, and the tertiary health effects stemming from an economic downturn.

Critical governance and financing reforms have been approved by the IMF so as to support countries and maintain their $1 trillion lending capacity as countries are facing unprecedented financing needs owing to the COVID-19 outbreak, resulting in studying the COVID-19 Outbreak – Impact Assessment on Healthcare Industry.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/covid-19-outbreak-healthcare-industry/request-sample

Furthermore, the increased cases of COVID-19 patients have led to the increased demand for medical ventilators globally. Out of it, approximately 5% of the total positive cases need ventilators to have proper breathing. Philips has aimed to double its production of hospital ventilators from 1000 a week to 2000 so ss to offers that all healthcare facilities to access the lifesaving equipment. Medtronic has increased the production of PD980 ventilators and is doubling its employee at its manufacturing plants that it can operate 24/7.

According to a report published by EY-FICCI, even having more than 60% share of bed capacity, the private healthcare sector’s financial performance was severely constrained even in the pre-COVID crisis. Owing to stringent lockdown measures being imposed to curtail the spread of coronavirus, hospitals are beholding a drop in both domestic and international patient footfalls and elective surgeries, thereby occupancy levels fall to approximately 40% by late March which was approx. 65-70% in the pre- COVID-19 era. There was also a drastic fall i/e/ approximately 80% inpatient visits at diagnostics labs.

The Singapore government has announced four packages in 2020 amounting to a total stimulus of S$63.7 billion (13% of GDP). Of which S$ 800 million is curtain the outbreak i.e to the Ministry of Health. The Indian Government has announced a stimulus package of 0.8% of GDP and an additional 150 billion rupees (approx. 0.1% of GDP) will be for health infrastructure including testing facilities for COVID-19, personal protective equipment, isolation beds, ICU beds, and ventilators.

The COVID-19 will change the life of every human being on this planet Earth. Healthcare stakeholders can initially address emergency cases related to delayed care, like cardiac or oncology conditions. However, a rapid framework is required to address behavioral health issues in order to understand the COVID-19 impact on the healthcare system.

Source: VynZ Research